Our data also provide evidence that resveratrol can attenuate NLRP3 inflammasome in a CIN model, as the level of renal NLRP3 in our CIN group was dramatically reduced by pretreatment with resveratrol in the RCIN group. Here, NLRP3 is linked to cervical squamous intraepithelial neoplasia.